Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study

Chao Mei, Tian Wang,Baoli Xu,Sanlan Wu, Xuelin Zhang,Yongning Lv,Yu Zhang,Zhaoqian Liu,Weijing Gong

BMC Pulmonary Medicine(2024)

Cited 0|Views10
No score
Abstract
Cyclin D1 (CCND1) plays a pivotal role in cancer susceptibility and the platinum-based chemotherapy response. This study aims to assess the relationship between a common polymorphism (rs9344 G > A) in CCND1 gene with cancer susceptibility, platinum-based chemotherapy response, toxicities and prognosis of patients with lung cancer. This study involved 498 lung cancer patients and 213 healthy controls. Among them, 467 patients received at least two cycles of platinum-based chemotherapy. Unconditional logistical regression analysis and meta-analysis were performed to evaluate the associations. The lung adenocarcinoma risk was significantly higher in patients with AA than GG + GA genotype (adjusted OR = 1.755, 95
More
Translated text
Key words
Lung cancer,CCND1 rs9344,Platinum-based chemotherapy,Susceptibility,Prognosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined